Better together: a narrative review of academia and medical device industry collaborations toward sustainable kidney care

Clicks: 4
ID: 333324
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #207 of 209 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 209 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Chronic kidney disease is a leading cause of death and disability globally, with the greatest burden and most limited access to kidney therapies in low- and middle-income countries. Environmentally sustainable kidney care is increasingly recognized as essential. Structured, patient-informed collaboration between academia and the kidney medical device industry holds potential toward solving these problems. Methods We conducted a narrative review of partnerships between academia and industry in environmentally sustainable kidney care. A scoping search of PubMed, Google Scholar, CINAHL and the Cochrane Library was combined with targeted grey-literature searches of key organizations. Eligible sources describe partnership structures, governance, financing, environmental or social outcomes, or lessons learned. Findings were synthesized thematically, informed by patient perspective, then interpreted using a United Nations sustainable development partnership framework. Results Existing initiatives and consortia such as the International Society of Nephrology’s GREEN-K, the Kidney Health Initiative and KitNewCare illustrate the potential of multi-stakeholder collaboration to advance sustainable kidney care. Patient organizations, notably the European Kidney Patients’ Federation, emphasise that environmental initiatives must align with treatment quality, patient autonomy and equity. Industry-led innovations include water- and energy-efficient technologies, life-cycle assessment of processes and/or consumables, lower-impact concentrates and operational optimizations. Key barriers include heterogeneous regulatory requirements, limited materials circularity, public procurement that prioritizes cost over sustainability, and financial investments associated with device innovation. We envision partnering opportunities to both improve access to, and environmental sustainability of, kidney therapies. Conclusions Achieving low-carbon, resilient and equitable kidney care requires academia–industry partnerships that embed meaningful patient involvement, position industry as co-creator, and align incentives around shared clinical and environmental goals. Structured partnering frameworks can support transparent governance, harmonised metrics and scalable green innovation across the kidney medical device sector.
Reference Key
openalex_W7223173577 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marta Arias-Guillén, Juan Carlos Julián Mauro, Abdou Niang, Mónica Landazuri, Alfonso Sánchez, Caroline E. Stigant
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag375
URL
https://doi.org/10.1093/ckj/sfag375
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.